PRESS RELEASE published on 05/08/2024 at 12:00, 2 years 5 months ago Introducing Cannovation Clinical Research Partners, LLC: Pioneering the Future of BioPharmaceutical Cannabinoid-Based Therapeutics Cannovation Clinical Research Partners launches to pioneer cannabinoid research, development, and commercialization in pharmaceutical and biotech industries. Co-founded by Lisa Rich-Milan and Michael Zaccaria, the company aims to revolutionize medicine Innovation Pharmaceutical Biotech Cannovation Clinical Research Partners Cannabinoid Research
PRESS RELEASE published on 05/08/2024 at 11:32, 2 years 5 months ago Form notification of share repurchase programme Deutsche Post AG announces the increase of its share repurchase programme to €4 billion, aiming to buy back 130 million shares. The programme started on April 8th, 2022, and will end by December 2025 Share Buybacks Buyback Share Repurchase Programme Deutsche Post AG Deutsche Post Shares
PRESS RELEASE published on 05/08/2024 at 11:20, 2 years 5 months ago MGI – Media and Games Invest SE Proposal from MGI’s Nomination Committee (M8G) MGI - Media and Games Invest SE's Nomination Committee proposes expansion of the Board of Directors with Greg Coleman and Peter Huijboom, aiming to enhance media expertise and industry positioning Board Of Directors Nomination Committee MGI - Media And Games Invest SE Media Expertise Greg Coleman
PRESS RELEASE published on 05/08/2024 at 11:15, 2 years 5 months ago AdUX - Development within the board of directors AdUX announces changes within its Board of Directors, including the appointment of Ms. Catharina Hillström as Chair following Mr. Benjamin van de Vrie's proposed move to Azerion's Supervisory Board Board Of Directors AdUX Azerion Catharina Hillström Benjamin Van De Vrie
PRESS RELEASE published on 05/08/2024 at 11:09, 2 years 5 months ago EQS-Adhoc: After reaching the UEFA Champions League final, Borussia Dortmund again raises its earnings forecast for the 2023/2024 financial year Borussia Dortmund raises its earnings forecast for 2023/2024 after reaching the UEFA Champions League final. The consolidated net profit is now expected to be between EUR 40,000-50,000 thousand Earnings Forecast Borussia Dortmund UEFA Champions League 2023/2024 Financial Year EUR 40,000-50,000 Thousand
PRESS RELEASE published on 05/08/2024 at 11:05, 2 years 5 months ago GESCO SE announces result of the share buyback programme GESCO SE successfully completes share buyback program with a repartition rate of 94.9% and currently holds 4.72% treasury shares. Details on possible uses available on company website Share Buyback Investor Relations Treasury Shares GESCO SE Repurchased Shares
PRESS RELEASE published on 05/08/2024 at 10:01, 2 years 5 months ago Finnvera Group, Interim Management Statement 1 January–31 March 2024 Finnvera Group's Interim Management Statement for Jan-Mar 2024 shows a profit of EUR 54 million, with results and key figures detailed. CEO Pauli Heikkilä comments on the Finnish economy, operations, and future outlook Financial Performance Finnvera Group CEO Pauli Heikkilä Export Financing Interim Management Statement
PRESS RELEASE published on 05/08/2024 at 10:00, 2 years 5 months ago Sto SE & Co. KGaA: Consolidated turnover down by 5.9 % in the first quarter of 2024 compared to the same period of the previous year Sto SE & Co. KGaA reports a 5.9% decrease in consolidated turnover in Q1 2024 compared to the previous year due to weather conditions and lower investment in the building industry Financial Report Q1 2024 Sto SE & Co. KGaA Consolidated Turnover Building Industry
PRESS RELEASE published on 05/08/2024 at 09:02, 2 years 5 months ago Original-Research: Borussia Dortmund GmbH & Co KGaA (von NuWays AG): Kaufen Borussia Dortmund secures profits with UEFA advancements. Secure 5th place in Bundesliga ensures Champions League participation. Revenue decrease in Q3 prelims. Executive board changes announced. Buy recommendation with target price of EUR 5.50 Revenue Decrease Borussia Dortmund Champions League UEFA Executive Board Changes
PRESS RELEASE published on 05/08/2024 at 09:00, 2 years 5 months ago Inside Information / Other news releases Medincell suspends listing of shares on Euronext Paris pending press release. Innovative biopharmaceutical company developing long-acting injectable drugs Euronext Paris Biopharmaceutical Suspension Medincell Long-acting Injectable Drugs
Published on 10/30/2026 at 23:35, 1 day 16 hours ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 1 day 16 hours ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 19:00, 1 day 21 hours ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 2 days ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 11/01/2026 at 10:35, 5 hours 28 minutes ago Shenzhen Unveils APEC China 2026 Host-City Theme Song and Music Video
Published on 11/01/2026 at 05:00, 11 hours 3 minutes ago 2026 Yangtze River Culture Festival Opens in Yonglian Village, Zhangjiagang, Jiangsu
Published on 10/31/2026 at 16:35, 23 hours 28 minutes ago SKYWORTH Solar Announces Global Launch of Solavita as a Smart Microgrid Brand
Published on 10/30/2026 at 22:49, 1 day 17 hours ago EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 23:00, 1 day 17 hours ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 12:00, 2 days 4 hours ago Capital increase through exercise of subscription rights